A detailed history of Cary Street Partners Financial LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cary Street Partners Financial LLC holds 93,166 shares of BMY stock, worth $4.46 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
93,166
Previous 40,689 128.97%
Holding current value
$4.46 Million
Previous $2.3 Billion 146.91%
% of portfolio
0.18%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025

BUY
$53.9 - $63.11 $2.83 Million - $3.31 Million
52,477 Added 128.97%
93,166 $5.68 Billion
Q4 2024

Feb 14, 2025

BUY
$51.92 - $59.94 $2.11 Million - $2.44 Million
40,689 New
40,689 $2.3 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $102B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cary Street Partners Financial LLC Portfolio

Follow Cary Street Partners Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Financial LLC with notifications on news.